School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Insight Molecular Diagnostics Inc. IMDX

Healthcare · Diagnostics & Research

$3.37last close 2026-10-09 · market cap $110.28M · delayed data

Trailing returns

1M-17.80%
3M-30.52%
6M+5.97%
1Y-11.32%
5Y-94.89%

Basis: Adjusted daily closes.

What it does

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests.

Open IMDX in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies